ProcureCon Pharma US 2015 (past event)
November 04 - 06, 2015
Array
Practical Strategies for Sourcing in a Global Environment
08:00 - 08:40 Continental Breakfast
08:40 - 08:45 Welcome Remarks
08:45 - 09:00 Chairperson’s Opening Address
09:00 - 09:20 Take Hold of Opportunities for Scientific Innovation Produced by Global Megatrends
From pressure on natural resources to global demographic shifts to political change to rapid innovations in science and technology, the landscape for healthcare is rapidly changing. Forecasts show healthcare spending is due to double over the next 10 years as the population ages. How can you take into account these global trends to prepare for the future? What is on the horizon that you can get ready for now to help deliver products to patients?
Get insights on:
• The most pressing global megatrends
• How they are affecting the health of the national and global populations
• Where to partner with technological innovators to solve problems of sickness
Joe Bruns
Global Head Procurement Patient Access and Market InsightsNovartis Pharmaceuticals
Subs Tripathy
Global Head of Oncology Procurement and Head of Meetings, Congresses and EvNovartis
09:20 - 10:00 Industry Chat | Utilizing Contingent Labor Best Practices to Achieve Your Business Objectives
Business expansion and technologically demanding projects are driving a need for contingent labor, project-based services and independent contractors. How does a VMS help companies hire and manage the best workers quickly and efficiently?
Gain insight firsthand from current VMS users on:
• How best to align your program goals to those of your business
• Best practices for contingent workforce program design and implementation
• Top reporting strategies for ongoing improvement
10:00 - 10:40 Panel Discussion | Drive Efficiency and Foster Innovation through effective Procurement in R&D
Speakers:
James Tornos Director, Global Worldwide Procurement Pfizer
Frances Grote Senior Director - Clinical Operations Biogen Idec
Ratan Ratnesh Director, Clinical Outsourcing Otsuka America Pharmaceuitcals
Moderator:
Arash Azadegan Assistant Professor of Supply Chain Management Rutgers Business School
James Tornos Director, Global Worldwide Procurement Pfizer
Frances Grote Senior Director - Clinical Operations Biogen Idec
Ratan Ratnesh Director, Clinical Outsourcing Otsuka America Pharmaceuitcals
Moderator:
Arash Azadegan Assistant Professor of Supply Chain Management Rutgers Business School
Clinical and non-clinical activities as they relate to R&D are by and large the biggest categories of indirect spend for biopharma. With so many investments being made in drug R&D, how can procurement better support innovation and drive efficiency?
Find out how to:
• Better align with R&D and clinical stakeholders on the strategic side to maintain objectivity in sourcing for a relationship-based category
• Integrate with suppliers and roll out alliance management for the day-to-day operations of outsourced activities
• Work with CROs to define a strategy for data management that can show a broader perspective while being compliant with regulatory rules
• Examine R&D strategic needs at the global level to pinpoint opportunities for procurement participation to drive value and efficiency
10:40 - 11:25 Morning Refreshment & Networking Break
11:25 - 11:45 Creating a Flexible Organization and Striking a Balance Between Global Strategies and Working Locally to Deliver Value
What do global strategies look like that can be actioned at local levels? What degree of flexibility is necessary? When establishing global frameworks, how can you be sure they meet varying local and regional rules? How can you relate strategy back to what the business needs without going too far?
Find out how to:
• Build in flexibility to your structure to focus on key categories or leverage third parties
• Gain a good understanding of local conditions, country specific and business requirements
• Design category strategies for the global business
• Make sure your strategy delivers what your business partners need
11:45 - 12:05 Case Study | Innovative Procurement Solutions to Accelerate Pre-Clinical Research
Science is an art, and R&D is undoubtedly lengthy and costly. What opportunities are available for procurement to ease the pains of siloed information, from research to supplier bases? How can tactical functions be automated on the bench to accelerate innovation? How can strategic sourcing initiatives be designed to improve access to a broader market?
Find out how the R&D procurement team at AstraZeneca:
• Developed an innovation marketplace to simplify the search
• Embedded information on supplier and services to share knowledge globally
• Reduced cycle time in R&D, leading to significant cost reduction
Find out how the R&D procurement team at AstraZeneca:
• Developed an innovation marketplace to simplify the search
• Embedded information on supplier and services to share knowledge globally
• Reduced cycle time in R&D, leading to significant cost reduction
12:05 - 13:15 Roundtable Discussion Hour
Speakers:
Wali Salahuddin Sr. Manager, Advance Analytics and Data Innovations Johnson & Johnson
Kai Ding Global Indirect Sourcing Lead Alexion Pharmaceuticals
Joe O'Brien Director, Indirect Procurement Teva Pharmaceuticals
Jayme Bombo Senior Procurement Leader Leading Global Biopharmaceutical Company
Joe Bruns Global Head Procurement Patient Access and Market Insights Novartis Pharmaceuticals
Subs Tripathy Global Head of Oncology Procurement and Head of Meetings, Congresses and Ev Novartis
Wali Salahuddin Sr. Manager, Advance Analytics and Data Innovations Johnson & Johnson
Kai Ding Global Indirect Sourcing Lead Alexion Pharmaceuticals
Joe O'Brien Director, Indirect Procurement Teva Pharmaceuticals
Jayme Bombo Senior Procurement Leader Leading Global Biopharmaceutical Company
Joe Bruns Global Head Procurement Patient Access and Market Insights Novartis Pharmaceuticals
Subs Tripathy Global Head of Oncology Procurement and Head of Meetings, Congresses and Ev Novartis
Be sure to join these interactive roundtable sessions and take a deep dive into the specific areas you came to discuss. Opportunities to sit and learn from life science executives like these do not exist elsewhere. Take control of your own event experience. Don’t be shy! Ask questions (or answer them!) of other conference attendees who are dealing with the same challenges as you.
•Network with industry peers with very similar challenges, interests and responsibilities
•Take a deep dive into a niche topic in an intimate and informal setting moderated by a subject matter expert
•Don’t miss out on the discussions you want to participate in—you’ll get to select a new topic after 30 minutes
Roundtable Discussions:
1.Take Hold of Opportunities for Scientific Innovation Produced by Global Megatrends
Joe Bruns, Executive Director, Global Head of Oncology Strategic Sourcing and Productivity, Novartis
Subs Tripathy, Director, Global Finance, Novartis
2.Strike a Balance Between Global Strategies and Working Locally to Deliver Value
Jayme C. Bombo, Senior Procurement Leader, Leading Global Biopharmaceutical Company
3. Innovative Procurement Solutions to Accelerate Pre-Clinical Research
Brian Bonnell, Global Category Manager, Planning and Resource – Biotech, AstraZeneca
4.Data Consolidation and Defining Savings to Understand Spend From a Global Standpoint
Joe O’Brien, Director, Indirect Procurement, Teva Pharmaceuticals
5.Scaling Procurement to Grow With the Business
Kai Ding, Indirect Sourcing Lead, Global Procurement, Alexion Pharmaceuticals, Inc.
Joe O'Brien
Director, Indirect ProcurementTeva Pharmaceuticals
Joe Bruns
Global Head Procurement Patient Access and Market InsightsNovartis Pharmaceuticals
Subs Tripathy
Global Head of Oncology Procurement and Head of Meetings, Congresses and EvNovartis